Principles of Drug Action. The Basis of Pharmacology

Por Lennard, L
Publicado em 1991

Molecular aspects of anticancer drugs-DNA interactions. Volume 1

Por Lennard, L.
Publicado em 1994

Immunosuppressive drugs. Developments in anti-rejection therapy

Por Lennard, L.
Publicado em 1994

TPMT in the treatment of Crohn's disease with azathioprine

Por Lennard, L
Publicado em 2002

Therapeutic drug monitoring of cytotoxic drugs

Por Lennard, L
Publicado em 2001

Therapeutic drug monitoring of antimetabolic cytotoxic drugs

Por Lennard, L
Publicado em 1999

Non-compliance with oral chemotherapy in childhood leukaemia.

Por Lilleyman, J. S., Lennard, L.
Publicado em 1996

Human thiopurine methyltransferase activity varies with red blood cell age

Por Lennard, L, Chew, T S, Lilleyman, J S
Publicado em 2001

Profile of non-compliance in lymphoblastic leukaemia

Por Lancaster, D, Lennard, L, Lilleyman, J
Publicado em 1997

Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?

Por Lennard, L., Welch, J., Lilleyman, J. S.
Publicado em 1995

Mercaptopurine in childhood leukaemia: the effects of dose escalation on thioguanine nucleotide metabolites

Por LENNARD, L., WELCH, J., LILLEYMAN, J. S.
Publicado em 1996

Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6-mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia.

Por Lennard, L, Hale, J P, Lilleyman, J S
Publicado em 1993

The accumulation of mercaptopurine metabolites in age fractionated red blood cells.

Por Rostami-Hodjegan, A, Lennard, L, Lilleyman, J S
Publicado em 1995

Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance?

Por Davies, H A, Lennard, L, Lilleyman, J S
Publicado em 1993

Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?

Por Lennard, L., Davies, H. A., Lilleyman, J. S.
Publicado em 1993

The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia.

Por Lennard, L., Lilleyman, J. S., Maddocks, J. L.
Publicado em 1986

6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia.

Por Herber, S., Lennard, L., Lilleyman, J. S., Maddocks, J.
Publicado em 1982

Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity

Por Lennard, L., Welch, J. C., Lilleyman, J. S.
Publicado em 1997

Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.

Por Lennard, L, Gibson, B E, Nicole, T, Lilleyman, J S
Publicado em 1993

Severe megaloblastic anaemia associated with abnormal azathioprine metabolism.

Por Lennard, L, Murphy, M F, Maddocks, J L
Publicado em 1984